Zygomycosis: the re-emerging fungal infection

Kwon-Chung KJ, Bennett JE (1992) Medical mycology. Lea & Febiger, Philadelphia, p 866

Ribes JA, Vanover-Sams CL, Baker DJ (2000) Zygomycetes in human disease. Clin Microbiol Rev 13:236–301

Cavalier-Smith T (1998) A revised six-kingdom system of life. Biol Rev Camb Philos Soc 73:203–266

Jensen AB, Dromph KM (2005) The causal agents of “entomophthoramycosis” belong to two different orders: a suggestion for modification of the clinical nomenclature. Clin Microbiol Infect 11:249–250

Prabhu RM, Patel R (2004) Mucormycosis and entomophthoramycosis: a review of the clinical manifestations, diagnosis and treatment. Clin Microbiol Infect 10(Suppl 1):31–47

Sugar AM (2005) Agents of mucormycosis and related species. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas, and Bennett’s principles and practice of infectious diseases. Elsevier Churchill Livingstone, Philadelphia, pp 2973–2984

Gonzalez CE, Rinaldi MG, Sugar AM (2002) Zygomycosis. Infect Dis Clin North Am 16:895–914

Dromer F, McGinnis MR (2003) Zygomycosis. In: Anaissie EJ, McGinnis MR, Pfaller MA (eds) Clinical mycology. Churchill Livingstone, New York, pp 297–308

Ciferri R, Ashford BK (1929) New species of Mortierella isolated from human skin. P R J Pub Health Trop Med 5:134–143

Nicolau E, Evolcenu R (1947) Recherches mycologiques dans un cas de mycetome du pied a grains noirs. (Mortierella mycetomi). Annu Bull Dermatol 8:330–343

Roden MM, Zaoutis TE, Buchanan WL, Knudsen TA, Sarkisova TA, Schaufele RL, Sein M, Sein T, Chiou CC, Chu JH, Kontoyiannis DP, Walsh TJ (2005) Epidemiology and outcome of zygomycosis: a review of 929 reported cases. Clin Infect Dis 41:634–653

Rickerts V, Bohme A, Viertel A, Behrendt G, Jacobi V, Tintelnot K, Just-Nubling G (2000) Cluster of pulmonary infections caused by Cunninghamella bertholletiae in immunocompromised patients. Clin Infect Dis 31:910–913

Kontoyianis DP, Vartivarian S, Anaissie EJ, Samonis G, Bodey GP, Rinaldi M (1994) Infections due to Cunninghamella bertholletiae in patients with cancer: report of three cases and review. Clin Infect Dis 18:925–928

Zeilender S, Drenning D, Glauser FL, Bechard D (1990) Fatal Cunninghamella bertholletiae infection in an immunocompetent patient. Chest 97:1482–1483

Solano T, Atkins B, Tambosis E, Mann S, Gottlieb T (2000) Disseminated mucormycosis due to Saksenaea vasiformis in an immunocompetent adult. Clin Infect Dis 30:942–943

Weinberg WG, Wade BH, Cierny G III, Stacy D, Rinaldi MG (1993) Invasive infection due to Apophysomyces elegans in immunocompetent hosts. Clin Infect Dis 17:881–884

Kamalam A, Thambiah AS (1980) Cutaneous infection by Syncephalastrum. Sabouraudia 18:19–20

Verweij PE, Voss A, Donnelly JP, de Pauw BE, Meis JF (1997) Wooden sticks as the source of a pseudoepidemic of infection with Rhizopus microsporus var. rhizopodiformis among immunocompromised patients. J Clin Microbiol 35:2422–2423

Oliver MR, Van Voorhis WC, Boeckh M, Mattson D, Bowden RA (1996) Hepatic mucormycosis in a bone marrow transplant recipient who ingested naturopathic medicine. Clin Infect Dis 22:521–524

Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL (1998) The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: results of population-based laboratory active surveillance. Clin Infect Dis 27:1138–1147

Pagano L, Girmenia C, Mele L, Ricci P, Tosti ME, Nosari A, Buelli M, Picardi M, Allione B, Corvatta L, D’Antonio D, Montillo M, Melillo L, Chierichini A, Cenacchi A, Tonso A, Cudillo L, Candoni A, Savignano C, Bonini A, Martino P, Del Favero A (2001) Infections caused by filamentous fungi in patients with hematologic malignancies. A report of 391 cases by GIMEMA Infection Program. Haematologica 86:862–870

Marr KA, Carter RA, Crippa F, Wald A, Corey L (2002) Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 34:909–917

Husain S, Alexander BD, Munoz P, Avery RK, Houston S, Pruett T, Jacobs R, Dominguez EA, Tollemar JG, Baumgarten K, Yu CM, Wagener MM, Linden P, Kusne S, Singh N (2003) Opportunistic mycelial fungal infections in organ transplant recipients: emerging importance of non-Aspergillus mycelial fungi. Clin Infect Dis 37:221–229

Jorens PG, Boelaert JR, Halloy V, Zamora R, Schneider YJ, Herman AG (1995) Human and rat macrophages mediate fungistatic activity against Rhizopus species differently: in vitro and ex vivo studies. Infect Immun 63:4489–4494

Helderman JH, Cooper HS, Mann J (1974) Chronic phycomycosis in a controlled diabetic. Ann Intern Med 80:419

Greenberg RN, Scott LJ, Vaughn HH, Ribes JA (2004) Zygomycosis (mucormycosis): emerging clinical importance and new treatments. Curr Opin Infect Dis 17:517–525

Nithyanandam S, Jacob MS, Battu RR, Thomas RK, Correa MA, D’Souza O (2003) Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes. Indian J Ophthalmol 51:231–236

Joshi N, Caputo GM, Weitekamp MR, Karchmer AW (1999) Infections in patients with diabetes mellitus. N Engl J Med 341:1906–1912

Bhansali A, Bhadada S, Sharma A, Suresh V, Gupta A, Singh P, Chakarbarti A, Dash RJ (2004) Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes. Postgrad Med J 80:670–674

Artis WM, Fountain JA, Delcher HK, Jones HE (1982) A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability. Diabetes 31:1109–1114

Skahan KJ, Wong B, Armstrong D (1991) Clinical manifestations and management of mucormycosis in the compromised patient. In: Warnock DW, Richardson MD (eds) Fungal infections in the compromised patient. Wiley, Indianapolis, pp 153–190

Gupta KL, Radotra BD, Sakhuja V, Banerjee AK, Chugh KS (1989) Mucormycosis in patients with renal failure. Ren Fail 11:195–199

Espinoza CG, Halkias DG (1983) Pulmonary mucormycosis as a complication of chronic salicylate poisoning. Am J Clin Pathol 80:508–511

Lewis LL, Hawkins HK, Edwards MS (1990) Disseminated mucormycosis in an infant with methylmalonicaciduria. Pediatr Infect Dis J 9:851–854

Boelaert JR, Fenves AZ, Coburn JW (1991) Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry. Am J Kidney Dis 18:660–667

Sugar AM (1992) Mucormycosis. Clin Infect Dis 14(Suppl 1):S126–S129

McNab AA, McKelvie P (1997) Iron overload is a risk factor for zygomycosis. Arch Ophthalmol 115:919–921

Maertens J, Demuynck H, Verbeken EK, Zachee P, Verhoef GE, Vandenberghe P, Boogaerts MA (1999) Mucormycosis in allogeneic bone marrow transplant recipients: report of five cases and review of the role of iron overload in the pathogenesis. Bone Marrow Transplant 24:307–312

de Locht M, Boelaert JR, Schneider YJ (1994) Iron uptake from ferrioxamine and from ferrirhizoferrin by germinating spores of Rhizopus microsporus. Biochem Pharmacol 47:1843–1850

Abe F, Inaba H, Katoh T, Hotchi M (1990) Effects of iron and desferrioxamine on Rhizopus infection. Mycopathologia 110:87–91

Boelaert JR, de Locht M, Van Cutsem J, Kerrels V, Cantinieaux B, Verdonck A, Van Landuyt HW, Schneider YJ (1993) Mucormycosis during deferoxamine therapy is a siderophore-mediated infection. In vitro and in vivo animal studies. J Clin Invest 91:1979–1986

Richardson MD, Warnock DW (2003) Mucormycosis. In: Richardson MD, Warnock DW (eds) Fungal infection diagnosis and management. Blackwell, Oxford, pp 230–240

Morrison VA, McGlave PB (1993) Mucormycosis in the BMT population. Bone Marrow Transplant 11:383–388

Penalver FJ, Romero R, Fores R, Cabrera R, Briz M, Fernandez M (1998) Mucormycosis and hemopoietic transplants. Haematologica 83:950–951

Pavie J, Lafaurie M, Lacroix C, Marie Zagdanski A, Debrosse D, Socie G, Derouin F, Gluckman E, Michel Molina J (2004) Successful treatment of pulmonary mucormycosis in an allogenic bone-marrow transplant recipient with combined medical and surgical therapy. Scand J Infect Dis 36:767–769

Van den Saffele JK, Boelaert JR (1996) Zygomycosis in HIV-positive patients: a review of the literature. Mycoses 39:77–84

Nagy-Agren SE, Chu P, Smith GJ, Waskin HA, Altice FL (1995) Zygomycosis (mucormycosis) and HIV infection: report of three cases and review. J Acquir Immune Defic Syndr Hum Retrovirol 10:441–449

Blatt SP, Lucey DR, DeHoff D, Zellmer RB (1991) Rhinocerebral zygomycosis in a patient with AIDS. J Infect Dis 164:215–216

Sanchez MR, Ponge-Wilson I, Moy JA, Rosenthal S (1994) Zygomycosis and HIV infection. J Am Acad Dermatol 30:904–908

Johnson PC, Satterwhite TK, Monheit JE, Parks D (1987) Primary cutaneous mucormycosis in trauma patients. J Trauma 27:437–441

Cooter RD, Lim IS, Ellis DH, Leitch IO (1990) Burn wound zygomycosis caused by Apophysomyces elegans. J Clin Microbiol 28:2151–2153

Nash G, Foley FD, Goodwin MN Jr, Bruck HM, Greenwald KA, Pruitt BA Jr (1971) Fungal burn wound infection. JAMA 215:1664–1666

Sun QN, Fothergill AW, McCarthy DI, Rinaldi MG, Graybill JR (2002) In vitro activities of posaconazole, itraconazole, voriconazole, amphotericin B, and fluconazole against 37 clinical isolates of zygomycetes. Antimicrob Agents Chemother 46:1581–1582

Ritz N, Ammann RA, Aebischer CC, Gugger M, Jaton K, Schmid RA, Aebi C (2005) Failure of voriconazole to cure disseminated zygomycosis in an immunocompromised child. Eur J Pediatr 164:231–235

Kobayashi K, Kami M, Murashige N, Kishi Y, Fujisaki G, Mitamura T (2004) Breakthrough zygomycosis during voriconazole treatment for invasive aspergillosis. Haematologica 89:ECR42

Marty FM, Cosimi LA, Baden LR (2004) Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med 350:950–952

Oren I (2005) Breakthrough zygomycosis during empirical voriconazole therapy in febrile patients with neutropenia. Clin Infect Dis 40:770–771

Vigouroux S, Morin O, Moreau P, Mechinaud F, Morineau N, Mahe B, Chevallier P, Guillaume T, Dubruille V, Harousseau JL, Milpied N (2005) Zygomycosis after prolonged use of voriconazole in immunocompromised patients with hematologic disease: attention required. Clin Infect Dis 40:e35–e37

Siwek GT, Dodgson KJ, de Magalhaes-Silverman M, Bartelt LA, Kilborn SB, Hoth PL, Diekema DJ, Pfaller MA (2004) Invasive zygomycosis in hematopoietic stem cell transplant recipients receiving voriconazole prophylaxis. Clin Infect Dis 39:584–587

Mattner F, Weissbrodt H, Strueber M (2004) Two case reports: fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient. Scand J Infect Dis 36:312–314

Imhof A, Balajee SA, Fredricks DN, Englund JA, Marr KA (2004) Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole. Clin Infect Dis 39:743–746

Kontoyiannis DP, Lionakis MS, Lewis RE, Chamilos G, Healy M, Perego C, Safdar A, Kantarjian H, Champlin R, Walsh TJ, Raad II (2005) Zygomycosis in a tertiary-care cancer center in the era of Aspergillus-active antifungal therapy: a case-control observational study of 27 recent cases. J Infect Dis 191:1350–1359

Park BJ, Kontoyiannis DP, Pappas PG, Wannemuehler KA, Anaissie E, Fridkin SK, Walsh TJ, and the Transnet Investigators (2004) Comparison of zygomycosis and fusariosis to invasive aspergillosis (IA) among transplant recipients reporting to TRANSNET. In: Program and abstracts of the 44th ICAAC. Abstract no. M-666

Safdar A, O’Brien S, Kouri IF (2004) Efficacy and feasibility of aerosolized amphotericin B lipid complex therapy in caspofungin breakthrough pulmonary zygomycosis. Bone Marrow Transplant 34:467–468

Kontoyiannis DP, Wessel VC, Bodey GP, Rolston KV (2000) Zygomycosis in the 1990s in a tertiary-care cancer center. Clin Infect Dis 30:851–856

Kauffman CA (2004) Zygomycosis: reemergence of an old pathogen. Clin Infect Dis 39:588–590

Yohai RA, Bullock JD, Aziz AA, Markert RJ (1994) Survival factors in rhino-orbital-cerebral mucormycosis. Surv Ophthalmol 39:3–22

Espinel-Ingroff A, Oakley LA, Kerkering TM (1987) Opportunistic zygomycotic infections. A literature review. Mycopathologia 97:33–41

Scharf JL, Soliman AM (2004) Chronic Rhizopus invasive fungal rhinosinusitis in an immunocompetent host. Laryngoscope 114:1533–1535

Brown SR, Shah IA, Grinstead M (1998) Rhinocerebral mucormycosis caused by Apophysomyces elegans. Am J Rhinol 12:289–292

Hussain S, Salahuddin N, Ahmad I, Salahuddin I, Jooma R (1995) Rhinocerebral invasive mycosis: occurrence in immunocompetent individuals. Eur J Radiol 20:151–155

Radner AB, Witt MD, Edwards JE Jr (1995) Acute invasive rhinocerebral zygomycosis in an otherwise healthy patient: case report and review. Clin Infect Dis 20:163–166

Feeley MA, Righi PD, Davis TE, Greist A (1999) Mucormycosis of the paranasal sinuses and septum. Otolaryngol Head Neck Surg 120:750

Ferguson BJ (2000) Mucormycosis of the nose and paranasal sinuses. Otolaryngol Clin North Am 33:349–365

Kim IT, Shim JY, Jung BY (2001) Serous retinal detachment in a patient with rhino-orbital mucormycosis. Jpn J Ophthalmol 45:301–304

Humphry RC, Wright G, Rich WJ, Simpson R (1989) Acute proptosis and blindness in a patient with orbital phycomycosis. J R Soc Med 82:304–305

Tsai TC, Hou CC, Chou MS, Chen WH, Liu JS (1999) Rhinosino-orbital mucormycosis causing cavernous sinus thrombosis and internal carotid artery occlusion: radiological findings in a patient with treatment failure. Kaohsiung J Med Sci 15:556–561

Delbrouck C, Jacobs F, Fernandez Aguilar S, Devroede B, Choufani G, Hassid S (2004) Carotid artery occlusion due to fulminant rhinocerebral mucormycosis. Acta Otorhinolaryngol Belg 58:135–140

Sehgal A, Raghavendran M, Kumar D, Srivastava A, Dubey D, Kumar A (2004) Rhinocerebral mucormycosis causing basilar artery aneurysm with concomitant fungal colonic perforation in renal allograft recipient: a case report. Transplantation 78:949–950

Terk MR, Underwood DJ, Zee CS, Colletti PM (1992) MR imaging in rhinocerebral and intracranial mucormycosis with CT and pathologic correlation. Magn Reson Imaging 10:81–87

Garces P, Mueller D, Trevenen C (1994) Rhinocerebral mucormycosis in a child with leukemia: CT and MRI findings. Pediatr Radiol 24:50–51

Tedder M, Spratt JA, Anstadt MP, Hegde SS, Tedder SD, Lowe JE (1994) Pulmonary mucormycosis: results of medical and surgical therapy. Ann Thorac Surg 57:1044–1050

Gupta KL, Khullar DK, Behera D, Radotra BD, Sakhuja V (1998) Pulmonary mucormycosis presenting as fatal massive haemoptysis in a renal transplant recipient. Nephrol Dial Transplant 13:3258–3260

Kitabayashi A, Hirokawa M, Yamaguchi A, Takatsu H, Miura AB (1998) Invasive pulmonary mucormycosis with rupture of the thoracic aorta. Am J Hematol 58:326–329

Passamonte PM, Dix JD (1985) Nosocomial pulmonary mucormycosis with fatal massive hemoptysis. Am J Med Sci 289:65–67

Connor BA, Anderson RJ, Smith JW (1979) Mucor mediastinitis. Chest 75:525–526

Hsu JW, Chiang CD (1996) A case report of novel roentgenographic finding in pulmonary zygomycosis: thickening of the posterior tracheal band. Kaohsiung J Med Sci 12:595–600

Rubin SA, Chaljub G, Winer-Muram HT, Flicker S (1992) Pulmonary zygomycosis: a radiographic and clinical spectrum. J Thorac Imaging 7:85–90

McAdams HP, Rosado de Christenson M, Strollo DC, Patz EF Jr (1997) Pulmonary mucormycosis: radiologic findings in 32 cases. AJR Am J Roentgenol 168:1541–1548

Dykhuizen RS, Kerr KN, Soutar RL (1994) Air crescent sign and fatal haemoptysis in pulmonary mucormycosis. Scand J Infect Dis 26:498–501

Funada H, Misawa T, Nakao S, Saga T, Hattori KI (1984) The air crescent sign of invasive pulmonary mucormycosis in acute leukemia. Cancer 53:2721–2723

Chamilos G, Marom EM, Lewis RE, Lionakis MS, Kontoyiannis DP (2005) Predictors of pulmonary zygomycosis versus invasive pulmonary aspergillosis in patients with cancer. Clin Infect Dis 41:60–66

Adam RD, Hunter G, DiTomasso J, Comerci G Jr (1994) Mucormycosis: emerging prominence of cutaneous infections. Clin Infect Dis 19:67–76

Hata TR, Johnson RA, Barnhill R, Dover JS (1995) Ecthymalike lesions on the leg of an immunocompromised patient. Primary cutaneous mucormycosis. Arch Dermatol 131:833–834, 836–837

Michalak DM, Cooney DR, Rhodes KH, Telander RL, Kleinberg F (1980) Gastrointestinal mucormycoses in infants and children: a cause of gangrenous intestinal cellulitis and perforation. J Pediatr Surg 15:320–324

Ismail MH, Hodkinson HJ, Setzen G, Sofianos C, Hale MJ (1990) Gastric mucormycosis. Trop Gastroenterol 11:103–105

Lyon DT, Schubert TT, Mantia AG, Kaplan MH (1979) Phycomycosis of the gastrointestinal tract. Am J Gastroenterol 72:379–394

Virk SS, Singh RP, Arora AS, Grewal JS, Puri H (2004) Gastric zygomycosis—an unusual cause of massive upper gastrointestinal bleed. Indian J Gastroenterol 23:146–147

Siu KL, Lee WH (2004) A rare cause of intestinal perforation in an extreme low birth weight infant—gastrointestinal mucormycosis: a case report. J Perinatol 24:319–321

Ingram CW, Sennesh J, Cooper JN, Perfect JR (1989) Disseminated zygomycosis: report of four cases and review. Rev Infect Dis 11:741–754

Basti A, Taylor S, Tschopp M, Sztajzel J (2004) Fatal fulminant myocarditis caused by disseminated mucormycosis. Heart 90:e60

Frater JL, Hall GS, Procop GW (2001) Histologic features of zygomycosis: emphasis on perineural invasion and fungal morphology. Arch Pathol Lab Med 125:375–378

Parfrey NA (1986) Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases. Medicine (Baltimore) 65:113–123

Glazer M, Nusair S, Breuer R, Lafair J, Sherman Y, Berkman N (2000) The role of BAL in the diagnosis of pulmonary mucormycosis. Chest 117:279–282

Ruchel R, Margraf S (1993) Rapid microscopical diagnosis of deep-seated mycoses following maceration of fresh specimens and staining with optical brighteners. Mycoses 36:239–242

Crissey JT, Lang H, Parish LC (1995) Manual of medical mycology. Blackwell Science, Cambridge, p 263

National Committee for Clinical Laboratory Standards (2002) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved standard M38-A. NCCLS, Wayne, Pennsylvania

Espinel-Ingroff A (2001) Comparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi. J Clin Microbiol 39:1360–1367

Espinel-Ingroff A (2000) Clinical utility of in vitro antifungal susceptibility testing. Rev Esp Quimioter 13:161–166

Dannaoui E, Afeltra J, Meis JF, Verweij PE (2002) In vitro susceptibilities of zygomycetes to combinations of antimicrobial agents. Antimicrob Agents Chemother 46:2708–2711

Espinel-Ingroff A (2003) In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature. Rev Iberoam Micol 20:121–136

Dannaoui E, Meletiadis J, Mouton JW, Meis JF, Verweij PE (2003) In vitro susceptibilities of zygomycetes to conventional and new antifungals. J Antimicrob Chemother 51:45–52

Ibrahim AS, Bowman JC, Avanessian V, Brown K, Spellberg B, Edwards JE Jr, Douglas CM (2005) Caspofungin inhibits Rhizopus oryzae 1,3-beta-d-glucan synthase, lowers burden in brain measured by quantitative PCR, and improves survival at a low but not a high dose during murine disseminated zygomycosis. Antimicrob Agents Chemother 49:721–727

Spellberg B, Fu Y, Edwards JE Jr, Ibrahim AS (2005) Combination therapy with amphotericin B lipid complex and caspofungin acetate of disseminated zygomycosis in diabetic ketoacidotic mice. Antimicrob Agents Chemother 49:830–832

Verma A, Williams S, Trifilio S, Zembower T, Mehta J (2004) Successful treatment of concomitant pulmonary zygomycosis and aspergillosis with a combination of amphotericin B lipid complex, caspofungin, and voriconazole in a patient on immunosuppression for chronic graft-versus-host disease. Bone Marrow Transplant 33:1065–1066

Voitl P, Scheibenpflug C, Weber T, Janata O, Rokitansky AM (2002) Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B. Eur J Clin Microbiol Infect Dis 21:632–634

Rickerts V, Loeffler J, Bohme A, Einsele H, Just-Nubling G (2001) Diagnosis of disseminated zygomycosis using a polymerase chain reaction assay. Eur J Clin Microbiol Infect Dis 20:744–745

Hall L, Wohlfiel S, Roberts GD (2004) Experience with the MicroSeq D2 large-subunit ribosomal DNA sequencing kit for identification of filamentous fungi encountered in the clinical laboratory. J Clin Microbiol 42:622–626

Kobayashi M, Togitani K, Machida H, Uemura Y, Ohtsuki Y, Taguchi H (2004) Molecular polymerase chain reaction diagnosis of pulmonary mucormycosis caused by Cunninghamella bertholletiae. Respirology 9:397–401

Wysong DR, Waldorf AR (1987) Electrophoretic and immunoblot analyses of Rhizopus arrhizus antigens. J Clin Microbiol 25:358–363

Dannaoui E, Mouton JW, Meis JF, Verweij PE (2002) Efficacy of antifungal therapy in a nonneutropenic murine model of zygomycosis. Antimicrob Agents Chemother 46:1953–1959

Dannaoui E, Meis JF, Loebenberg D, Verweij PE (2003) Activity of posaconazole in treatment of experimental disseminated zygomycosis. Antimicrob Agents Chemother 47:3647–3650

Sun QN, Najvar LK, Bocanegra R, Loebenberg D, Graybill JR (2002) In vivo activity of posaconazole against Mucor spp. in an immunosuppressed-mouse model. Antimicrob Agents Chemother 46:2310–2312

Kofteridis DP, Karabekios S, Panagiotides JG, Bizakis J, Kyrmizakis D, Saridaki Z, Gikas A (2003) Successful treatment of rhinocerebral mucormycosis with liposomal amphotericin B and surgery in two diabetic patients with renal dysfunction. J Chemother 15:282–286

Herbrecht R, Letscher-Bru V, Bowden RA, Kusne S, Anaissie EJ, Graybill JR, Noskin GA, Oppenheim, Andres E, Pietrelli LA (2001) Treatment of 21 cases of invasive mucormycosis with amphotericin B colloidal dispersion. Eur J Clin Microbiol Infect Dis 20:460–466

Walsh TJ, Hiemenz JW, Seibel NL, Perfect JR, Horwith G, Lee L, Silber JL, DiNubile MJ, Reboli A, Bow E, Lister J, Anaissie EJ (1998) Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis 26:1383–1396

Crompton JA, Alexander D, Somerville T, Shihab FS (2004) Lipid-based amphotericin in pulmonary zygomycosis: safety and efficacy of high exposure in a renal allograft recipient. Transpl Infect Dis 6:183–187

Perfect JR (2004) Use of newer antifungal therapies in clinical practice: what do the data tell us? Oncology (Huntingt) 18:15–23

Perfect JR (2005) Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex. Clin Infect Dis 40(Suppl 6):S401–408

Strasser MD, Kennedy RJ, Adam RD (1996) Rhinocerebral mucormycosis. Therapy with amphotericin B lipid complex. Arch Intern Med 156:337–339

Weng DE, Wilson WH, Little R, Walsh TJ (1998) Successful medical management of isolated renal zygomycosis: case report and review. Clin Infect Dis 26:601–605

Gollard R, Rabb C, Larsen R, Chandrasoma P (1994) Isolated cerebral mucormycosis: case report and therapeutic considerations. Neurosurgery 34:174–177

Larkin JA, Montero JA (2003) Efficacy and safety of amphotericin B lipid complex for zygomycosis. Infect Med 20:201–206

Tobon AM, Arango M, Fernandez D, Restrepo A (2003) Mucormycosis (zygomycosis) in a heart–kidney transplant recipient: recovery after posaconazole therapy. Clin Infect Dis 36:1488–1491

Greenberg RN, Anstead G, Herbrecht R, Langston A, Marr K, Mullane K, Raad I, Schiller G, Schuster M, Van Burik J, Wingard JR, Hare R, Corcoran G (2003) Posaconazole (POS) experience in the treatment of zygomycosis. In: Program and abstracts of the 43rd interscience conference on antimicrobial agents and chemotherapy. Abstract no. M-1757

Herbrecht R (2004) Posaconazole: a potent, extended-spectrum triazole anti-fungal for the treatment of serious fungal infections. Int J Clin Pract 58:612–624

Boucher HW, Groll AH, Chiou CC, Walsh TJ (2004) Newer systemic antifungal agents: pharmacokinetics, safety and efficacy. Drugs 64:1997–2020

Raj P, Vella EJ, Bickerton RC (1998) Successful treatment of rhinocerebral mucormycosis by a combination of aggressive surgical debridement and the use of systemic liposomal amphotericin B and local therapy with nebulized amphotericin—a case report. J Laryngol Otol 112:367–370

Gil-Lamaignere C, Simitsopoulou M, Roilides E, Maloukou A, Winn RM, Walsh TJ (2005) Interferon-gamma and granulocyte-macrophage colony-stimulating factor augment the activity of polymorphonuclear leukocytes against medically important zygomycetes. J Infect Dis 191:1180–1187

Sahin B, Paydas S, Cosar E, Bicakci K, Hazar B (1996) Role of granulocyte colony-stimulating factor in the treatment of mucormycosis. Eur J Clin Microbiol Infect Dis 15:866–869

Garcia-Diaz JB, Palau L, Pankey GA (2001) Resolution of rhinocerebral zygomycosis associated with adjuvant administration of granulocyte-macrophage colony-stimulating factor. Clin Infect Dis 32:e145–e150

Wright DG, Robichaud KJ, Pizzo PA, Deisseroth AB (1981) Lethal pulmonary reactions associated with the combined use of amphotericin B and leukocyte transfusions. N Engl J Med 304:1185–1189

Ferguson BJ, Mitchell TG, Moon R, Camporesi EM, Farmer J (1988) Adjunctive hyperbaric oxygen for treatment of rhinocerebral mucormycosis. Rev Infect Dis 10:551–559

Bigliazzi C, Poletti V, Dell’Amore D, Saragoni L, Colby TV (2004) Disseminated basidiobolomycosis in an immunocompetent woman. J Clin Microbiol 42:1367–1369

Walker SD, Clark RV, King CT, Humphries JE, Lytle LS, Butkus DE (1992) Fatal disseminated Conidiobolus coronatus infection in a renal transplant patient. Am J Clin Pathol 98:559–564

Gugnani HC (1992) Entomophthoromycosis due to Conidiobolus. Eur J Epidemiol 8:391–396

Gugnani HC (1999) A review of zygomycosis due to Basidiobolus ranarum. Eur J Epidemiol 15:923–929

Mugerwa JW (1976) Subcutaneous phycomycosis in Uganda. Br J Dermatol 94:539–544

Martinson FD (1972) Clinical, epidemiological and therapeutic aspects of entomophthoromycosis. Ann Soc Belg Med Trop 52:329–342

Yousef OM, Smilack JD, Kerr DM, Ramsey R, Rosati L, Colby TV (1999) Gastrointestinal basidiobolomycosis. Morphologic findings in a cluster of six cases. Am J Clin Pathol 112:610–616

Khan ZU, Khoursheed M, Makar R, Al-Waheeb S, Al-Bader I, Al-Muzaini A, Chandy R, Mustafa AS (2001) Basidiobolus ranarum as an etiologic agent of gastrointestinal zygomycosis. J Clin Microbiol 39:2360–2363

Guarro J, Aguilar C, Pujol I (1999) In-vitro antifungal susceptibilities of Basidiobolus and Conidiobolus spp. strains. J Antimicrob Chemother 44:557–560

Dworzack DL, Pollock AS, Hodges GR, Barnes WG, Ajello L, Padhye A (1978) Zygomycosis of the maxillary sinus and palate caused by Basidiobolus haptosporus. Arch Intern Med 138:1274–1276

Pasha TM, Leighton JA, Smilack JD, Heppell J, Colby TV, Kaufman L (1997) Basidiobolomycosis: an unusual fungal infection mimicking inflammatory bowel disease. Gastroenterology 112:250–254

Taylor GD, Sekhon AS, Tyrrell DL, Goldsand G (1987) Rhinofacial zygomycosis caused by Conidiobolus coronatus: a case report including in vitro sensitivity to antimycotic agents. Am J Trop Med Hyg 36:398–401

Davis SR, Ellis DH, Goldwater P, Dimitriou S, Byard R (1994) First human culture-proven Australian case of entomophthoromycosis caused by Basidiobolus ranarum. J Med Vet Mycol 32:225–230

Foss NT, Rocha MR, Lima VT, Velludo MA, Roselino AM (1996) Entomophthoramycosis: therapeutic success by using amphotericin B and terbinafine. Dermatology 193:258–260